Cancel anytime
Cardinal Health Inc (CAH)CAH
- BUY Advisory
- Profitable SELL
- Loss-Inducing SELL
- Profit
- Loss
- PASS (Skip invest)*
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
09/10/2024: CAH (3-star) is a STRONG-BUY. BUY since 20 days. Profits (11.49%). Updated daily EoD!
Analysis of Past Upturns
Type: Stock | Upturn Star Rating | Today’s Advisory: Strong Buy |
Profit: 40.03% | Upturn Advisory Performance 4 | Avg. Invested days: 39 |
Profits based on simulation | Stock Returns Performance 3 | Last Close 09/10/2024 |
Type: Stock | Today’s Advisory: Strong Buy |
Profit: 40.03% | Avg. Invested days: 39 |
Upturn Star Rating | Stock Returns Performance 3 |
Profits based on simulation Last Close 09/10/2024 | Upturn Advisory Performance 4 |
Key Highlights
Company Size Large-Cap Stock | Market Capitalization 27.62B USD |
Price to earnings Ratio 32.27 | 1Y Target Price 117.41 |
Dividends yield (FY) 1.82% | Basic EPS (TTM) 3.45 |
Volume (30-day avg) 1990079 | Beta 0.62 |
52 Weeks Range 84.57 - 116.05 | Updated Date 09/17/2024 |
Company Size Large-Cap Stock | Market Capitalization 27.62B USD | Price to earnings Ratio 32.27 | 1Y Target Price 117.41 |
Dividends yield (FY) 1.82% | Basic EPS (TTM) 3.45 | Volume (30-day avg) 1990079 | Beta 0.62 |
52 Weeks Range 84.57 - 116.05 | Updated Date 09/17/2024 |
Earnings Date
Report Date - | When - |
Estimate - | Actual - |
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 0.38% | Operating Margin (TTM) 0.93% |
Management Effectiveness
Return on Assets (TTM) 3.03% | Return on Equity (TTM) - |
Revenue by Products
Revenue by Products - Current and Previous Year
Revenue by Geography
Revenue by Geography - Current and Previous Year
Valuation
Trailing PE 32.27 | Forward PE 14.62 |
Enterprise Value 26894162417 | Price to Sales(TTM) 0.12 |
Enterprise Value to Revenue 0.12 | Enterprise Value to EBITDA 13.71 |
Shares Outstanding 241962000 | Shares Floating 242479809 |
Percent Insiders 0.61 | Percent Institutions 89.79 |
Trailing PE 32.27 | Forward PE 14.62 | Enterprise Value 26894162417 | Price to Sales(TTM) 0.12 |
Enterprise Value to Revenue 0.12 | Enterprise Value to EBITDA 13.71 | Shares Outstanding 241962000 | Shares Floating 242479809 |
Percent Insiders 0.61 | Percent Institutions 89.79 |
Analyst Ratings
Rating 3.44 | Target Price 98.58 | Buy 3 |
Strong Buy 4 | Hold 9 | Sell 1 |
Strong Sell 1 |
Rating 3.44 | Target Price 98.58 | Buy 3 | Strong Buy 4 |
Hold 9 | Sell 1 | Strong Sell 1 |
AI Summarization
Cardinal Health Inc.: A Comprehensive Overview
Company Profile:
Detailed History and Background:
Cardinal Health Inc. (NYSE: CAH) is a global healthcare services and products company founded in 1971 as Cardinal Foods. The company has transitioned from a food distributor to a leading pharmaceutical and medical products distributor. In 1994, the company acquired Bergen Brunswig Corp., solidifying its position in the healthcare distribution market. Today, Cardinal Health operates in two segments: Pharmaceutical and Medical.
Core Business Areas:
- Pharmaceutical Distribution: This segment distributes prescription and over-the-counter medications to pharmacies, hospitals, and other healthcare facilities.
- Medical Products: This segment manufactures and distributes medical supplies, surgical instruments, and diagnostic equipment.
Leadership and Corporate Structure:
The company is led by Chairman and CEO Mike Kaufmann, who has been with Cardinal Health since 2019. The executive team comprises experienced industry professionals, overseeing various key functions. Cardinal Health operates a decentralized structure with business units focused on specific segments and markets.
Top Products and Market Share:
Top Products:
- Cardinal Health Brand Pharmaceuticals: Generic pharmaceuticals under their own brand.
- Medical-Surgical Products: Gloves, gowns, masks, and other surgical supplies.
- Cardinal Health atHome Solutions: Home infusion therapy and medical equipment services.
Market Share:
- Pharmaceutical Distribution: Cardinal Health holds the largest market share in the US, at approximately 29% (IQVIA, Q3 2023).
- Medical-Surgical Products: The company holds a significant market share, competing with other major players like Medline and McKesson.
- Specialty Distribution: Cardinal Health holds market leadership in several specialty areas like oncology and biopharmaceuticals.
Total Addressable Market:
The global healthcare market is massive, estimated to reach USD 11,908.9 billion by 2027, growing at a CAGR of 9.8% (Fortune Business Insights). Cardinal Health operates in key segments of this market, with significant opportunities for growth.
Financial Performance:
Recent Financial Performance:
- Revenue: USD 179.8 billion (FY 2023)
- Net Income: USD 2.0 billion (FY 2023)
- Profit Margin: 1.1% (FY 2023)
- Earnings per Share (EPS): USD 5.49 (FY 2023)
Year-over-Year Performance:
The company has experienced revenue growth in recent years, driven by increased demand for healthcare products and services. However, profit margins have remained relatively flat, and the company faces ongoing challenges in managing costs and competition.
Financial Strength:
Cardinal Health maintains a strong balance sheet with sufficient cash reserves and manageable debt levels, indicating financial stability.
Dividends and Shareholder Returns:
Dividend History:
Cardinal Health has a track record of paying dividends for over 30 years. The current annual dividend yield is approximately 2.5%.
Shareholder Returns:
Over the past 5 years, Cardinal Health shareholders have experienced a total return of approximately 25%, including dividends and share price appreciation.
Growth Trajectory:
Historical Growth:
Cardinal Health has experienced steady revenue growth over the past 10 years. However, the company needs to improve profit margins to sustain long-term value creation.
Future Growth Projections:
With the growing healthcare industry, Cardinal Health is well-positioned for further growth, especially in its specialty distribution and healthcare services segments. The company's focus on acquisitions and innovation will also drive future prospects.
Market Dynamics:
Industry Trends:
The global healthcare market is undergoing significant transformations, driven by factors like aging populations, technological advancements, and increased patient access to care.
Demand-Supply Scenario:
Demand for healthcare products and services is expected to keep increasing, creating opportunities for companies like Cardinal Health. However, supply chain disruptions and labor shortages pose challenges.
Technological Advancements:
Technological advancements in areas like automation, data analytics, and telehealth are impacting the healthcare distribution landscape. Cardinal Health is investing in these areas to remain competitive.
Market Position:
Cardinal Health is a well-established leader in healthcare distribution, leverag
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Cardinal Health Inc
Exchange | NYSE | Headquaters | Dublin, OH, United States |
IPO Launch date | 1987-12-31 | CEO & Director | Mr. Jason M. Hollar |
Sector | Healthcare | Website | https://www.cardinalhealth.com |
Industry | Medical Distribution | Full time employees | 47922 |
Headquaters | Dublin, OH, United States | ||
CEO & Director | Mr. Jason M. Hollar | ||
Website | https://www.cardinalhealth.com | ||
Website | https://www.cardinalhealth.com | ||
Full time employees | 47922 |
Cardinal Health, Inc. operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution. It distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products, as well as medical supplies. The company also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; offers pharmacy management services to hospitals; operates pharmacies, including pharmacies in community health centers; and repackages generic pharmaceuticals and over-the-counter healthcare products. In addition, it manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compression solution, incontinence, nutritional delivery, and wound care products; single-use surgical drapes, gowns, and apparel products; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. Further, the company distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile, and non-sterile procedure kits. Additionally, it manufactures, prepares, delivers, and distributes radiopharmaceuticals and related treatments; and optimizes direct shipments through integrated technology solutions. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.